CellaVision AB (publ) (LON:0MR5)
176.70
-4.70 (-2.59%)
At close: Sep 12, 2025
CellaVision AB Market Cap
CellaVision AB has a market cap or net worth of 332.81 million as of September 16, 2025. Its market cap has decreased by -30.64% in one year.
Market Cap
332.81M
Enterprise Value
322.89M
Revenue
57.68M
Ranking
n/a
PE Ratio
28.68
Stock Price
176.70
Market Cap Chart
Since May 28, 2007, CellaVision AB's market cap has increased from 27.41M to 332.81M, an increase of 1,114.36%. That is a compound annual growth rate of 14.61%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 15, 2025 | 332.81M | -11.33% |
Dec 30, 2024 | 375.34M | -4.64% |
Dec 29, 2023 | 393.61M | -9.49% |
Dec 30, 2022 | 434.88M | -31.55% |
Dec 30, 2021 | 635.34M | -3.33% |
Dec 30, 2020 | 657.25M | 5.60% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 182.89B |
HSBC Holdings | 173.71B |
Shell | 153.74B |
Unilever | 115.27B |
Rolls-Royce Holdings | 94.89B |
British American Tobacco p.l.c. | 90.78B |
Rio Tinto Group | 78.69B |
BP p.l.c. | 64.96B |